🇺🇸 FDA
Patent

US 8420612

Diabetes treatment methods and drug targets therefor

granted A61KA61K35/12

Quick answer

US patent 8420612 (Diabetes treatment methods and drug targets therefor) held by The Regents of the University of California expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K35/12